Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 7: Special Focus: VR6 Conference
Submit an article Journal homepage
1,361
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

Scott A. Halperin Canadian Center for Vaccinology; Dalhousie University, Capital Health, and the IWK Health Centre; Halifax, NS CanadaCorrespondence[email protected]
,
Brian J. Ward Vaccine Study Centre; Research Institute of the McGill University Health Centre; Montreal, QC Canada
,
Marc S Dionne Institut national de santé publique du Québec; Quebec City, QC Canada
,
Joanne M. Langley Canadian Center for Vaccinology; Dalhousie University, Capital Health, and the IWK Health Centre; Halifax, NS Canada
,
Shelly A. McNeil Canadian Center for Vaccinology; Dalhousie University, Capital Health, and the IWK Health Centre; Halifax, NS Canada
,
Bruce Smith Canadian Center for Vaccinology; Dalhousie University, Capital Health, and the IWK Health Centre; Halifax, NS Canada; Department of Mathematics and Statistics; Dalhousie University; Halifax, NS Canada
,
Donna MacKinnon-Cameron Canadian Center for Vaccinology; Dalhousie University, Capital Health, and the IWK Health Centre; Halifax, NS Canada
,
William L. Heyward Dynavax Technologies Corporation; Berkeley, CA USA
&
J. Tyler Martin Dynavax Technologies Corporation; Berkeley, CA USA
 show all
Pages 1438-1444 | Received 23 Jan 2013, Accepted 11 Mar 2013, Published online: 09 Apr 2013

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alicja E Grzegorzewska. (2015) Prophylactic vaccinations in chronic kidney disease: Current status. Human Vaccines & Immunotherapeutics 11:11, pages 2599-2605.
Read now
Alicja E Grzegorzewska. (2014) Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines. Expert Review of Vaccines 13:11, pages 1317-1326.
Read now
Roy Mathew, Darius Mason & Jeffrey S Kennedy. (2014) Vaccination issues in patients with chronic kidney disease. Expert Review of Vaccines 13:2, pages 285-298.
Read now

Articles from other publishers (15)

Israel Junior Borges do Nascimento, Agnieszka Pac, Fernando Zanghelini, Vinicius T Civile, Nadine E Correa & Hebatullah M Abdulazeem. (2023) Hepatitis B immunisation for adults with end-stage kidney disease. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Joshua Y Kwon, Nader D Daoud, Jana G Hashash, Michael F Picco & Francis A Farraye. (2023) Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 29:2, pages 254-259.
Crossref
Federico Alejandro Di Lello, Alfredo Pedro Martínez & Diego Martín Flichman. (2022) Insights into induction of the immune response by the hepatitis B vaccine. World Journal of Gastroenterology 28:31, pages 4249-4262.
Crossref
Özgür M. Koc, Philippe de Smedt, Cécile Kremer, Geert Robaeys, Pierre van Damme, Niel Hens, Jorge Almeida, Frank Falkenberg, Paul Savelkoul & Astrid Oude Lashof. (2021) Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial. Liver International 41:10, pages 2318-2327.
Crossref
Özgür M. Koc, Dirk Kuypers, Lieven J Dupont, Robin Vos, Jan M. Van Keer, Johan Van Cleemput, Geert Robaeys, Astrid Oude Lashof, Matthijs Kramer, Geert Verleden, Jef Verbeek & Frederik Nevens. (2020) The effect of universal infant vaccination on the prevalence of hepatitis B immunity in adult solid organ transplant candidates. Journal of Viral Hepatitis 28:1, pages 105-111.
Crossref
Elizabeth M. Rosenthal, Eric W. Hall, Eli S. Rosenberg, Aaron Harris, Noele P. Nelson & Sarah Schillie. (2020) Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine 38:51, pages 8206-8215.
Crossref
Stijn F H Raven, Christian J P A Hoebe, Ann C T M Vossen, Leo G Visser, Jeannine L A Hautvast, Anna H E Roukens & Jim E van Steenbergen. (2020) Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial. The Lancet Infectious Diseases 20:1, pages 92-101.
Crossref
Randall N. Hyer & Robert S. Janssen. (2019) Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years. Vaccine 37:39, pages 5854-5861.
Crossref
Tara Vinyette Saco, Alexandra T. Strauss & Dennis K. Ledford. (2018) Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 121:3, pages 320-327.
Crossref
Sarah Schillie, Aaron Harris, Ruth Link-Gelles, José Romero, John Ward & Noele Nelson. (2018) Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant. MMWR. Morbidity and Mortality Weekly Report 67:15, pages 455-458.
Crossref
Frédérique Delannois, Camille Planty, Giulia Giordano, Eric Destexhe, Dinesh Stanislaus, Fernanda Tavares Da Silva, Jens-Ulrich Stegmann, Karen Thacker, Lucie Reynaud, Nathalie Garçon & Lawrence Segal. (2018) Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits. Reproductive Toxicology 75, pages 110-120.
Crossref
Werner Dammermann, Frank Bentzien, Eva-Maria Stiel, Claudia Kühne, Sebastian Ullrich, Julian Schulze zur Wiesch & Stefan Lüth. (2015) Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients. Journal of Translational Medicine 13:1.
Crossref
Steven BlackEnnio De GregorioRino Rappuoli. (2015) Developing vaccines for an aging population. Science Translational Medicine 7:281.
Crossref
Geert Leroux-Roels. (2014) Old and new adjuvants for hepatitis B vaccines. Medical Microbiology and Immunology 204:1, pages 69-78.
Crossref
Werner Dammermann, Lisa Wollenberg, Frank Bentzien, Ansgar Lohse & Stefan Lüth. (2013) Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses. Journal of Immunological Methods 396:1-2, pages 107-115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.